Thus, we inhibited PRKDC expression with NU7441, which led to inhibition of the expression of AKT and mesenchymal markers as well as CRC cell migration and invasion, whereas the expression of E-Cadherin was upregulated (Fig. 7). The gene discussed is PRKDC; the disease is colorectal carcinoma.